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ABSTRACT
The clinical syndrome of mitral insufficiency is a common consequence of mitral valve (MV) prolapse, when the MV leaflets do not seal the closed
orifice and blood regurgitates back to the atrium during ventricular contraction. There are different types of MV prolapse that may influence the
degree of regurgitation also in relation to the left ventricle (LV) geometry. This study aims to provide some insight into the fluid dynamics of MV
insufficiency in view of improving the different measurements available in the clinical setting. The analysis is performed by a computational fluid
dynamics model coupled with an asymptotic model of the MV motion. The computational fluid dynamics solution uses the immersed boundary
method that is efficiently integrated with clinical imaging technologies. Healthy and dilated LVs obtained by multislice cardiac MRI are combined
with simplified models of healthy and pathological MVs deduced from computed tomography and 4D-transesophageal echocardiography. The
results demonstrated the properties of false regurgitation, blood that did not cross the open MV orifice and returns into the atrium during the back-
ward motion of the MV leaflets, whose entity should be accounted when evaluating small regurgitation. The regurgitating volume is found to be
proportional to the effective orifice area, with the limited dependence of the LV geometry and type of prolapse. These affect the percentage of old
blood returning to the atrium which may be associated with thrombogenic risk.
VC 2019 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://
creativecommons.org/licenses/by/4.0/). https://doi.org/10.1063/1.5097245
I. INTRODUCTION
Mitral valve prolapse (MVP) is the common cause of the mitral
regurgitation (MR) that affects approximately 2.4% of the popula-
tion,10 which is typically caused by myxomatous degeneration of the
valve.20 Clinical classification of MR is based Carpentier’s1 functional
characterization of the leaflets, which identifies the anterolateral,
medial, and posteromedial cusps of the posterior leaflet as P1, P2, and
P3 and the anterior leaflet as A1, A2, and A3. It classifies MR of the
individual leaflet based on its movements in three types. In type I MR,
the leaflets have a normal movement and regurgitation is imputable to
annular dilatation and incomplete coaptation of the leaflet or insuffi-
cient surface of coaptation; in type II MR, the leaflets are prolapsed or
hypermobile, which can be caused by elongation or rupture of chordae
tendineae or by lengthening or rupture of the papillary muscles.
Finally, in type III MR, the leaflets have a limited movement caused by
their stiffening and retraction or calcification.
Different methods have been introduced for evaluating MR. The
vena contracta method19 estimates the size of the regurgitant orifice by
measuring the minimum diameter of the regurgitant blood jet; then,
small measurement errors correspond to larger volumetric
quantification errors, which represent a limitation given by a large
inter- and intraoperator variability.24 The Proximal Isosurface
Velocity Area (PISA) method evaluates the MR volume based on the
2D Color-Doppler image of the converging flow proximal to the ori-
fice, the velocity is shown with different colors, and the assumption of
hemispheric converging flow allows estimating the flow rate based on
the value of one isovelocity contour. This method is the most utilized
for its simplicity, but measures are often subject to error18 because the
regurgitant area is not hemispherical; often, it is at half-moon or ellip-
tical; moreover, the PISA calculation relies on instantaneous measures
that are extended to the cardiac cycle for a volumetric estimation (typi-
cally assuming a proportion with the velocity trace measured with
Doppler at the LV outflow). In recent years, the increasing diffusion of
cardiac magnetic resonance (CMR) allows more accurate evaluations
of MR. High quality phase-contrast CMR with velocity-encoded imag-
ing is used for estimating the aortic flow and calculates the absolute
regurgitation volume from the difference volume rate in the left ventri-
cle (LV). This approach is considered the most reliable although it cal-
culates MR from a difference, rather than directly on the mitral valve
(MV), presenting some degree of variability.17 The effective orifice
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area (EOA)8,13,14 represents a more structural measure of MV insuffi-
ciency; this approach also presents various limitations3 partly imput-
able to the difficulty of measuring the EOA directly from images of the
MV orifice (MVO).
Although these methods provide an assessment for MR in the
routine clinical environment, the description of the flow phenomena
involved in MR is certainly incomplete and several dysfunctional states
can largely differ in the fluid dynamics about the MV despite similar
levels of MR or similar symptoms with different MR patterns.
This study aims to get deeper insight into the flow phenomena
associated with MR. This is achieved by reproducing, using direct
numerical simulation (DNS), the fluid dynamics in the LV in corre-
spondence with pathologic MVPs obtained from clinical images. The
focus of this study is on blood motion, and a simplified model for
flow-driven MV motion is employed. This approach allows estimating
the cardiac fluid dynamics associated with different types and gravity
of MVPs and how the actual regurgitated volume is correlated with
EOA. It will analyze the wash-out of the LV as well as the residence
time properties of the regurgitant blood that could reflect in additional
risk factors.11,12,22
II. RESULTS
A. Fluid dynamics in healthy and dilated LV
In this section, we describe the fluid dynamics that develops in
normal and dilated LV geometries in the presence of the different MV
morphologies described in Sec. IVA. The normal LV is characterized
by EDV ¼ 113:47ml, ESV¼46:52ml, StrokevolumeðSVÞ¼66:95ml,
and ejection-fraction EF¼ SVEDV¼59%.
The flow field in the normal LV at peak diastole is shown in Figs.
1(a)–1(c) in correspondence with (a) Healthy, (b) P3, and (c) P2 MVs.
The flow with healthy MV presents the typical asymmetric vortex ring
that enters the LV, the P3 case shows a vortex ring that deviates and
breaks down when impacting the posterior wall, and finally, the mitral
jet in the P2 MV is characterized by an irregular flow that enters in
depth into the center of the LV probably because of the slightly
reduced dimension of the MVO. Figures 1(d)–1(f) reports the corre-
sponding concentration field at peak systole. The healthy case eviden-
ces blood that is well mixed between old and fresh blood in the entire
chamber; differently, the prolapse MVs are associated with the greater
presence of old blood near the apex and displays regurgitation in
atrium.
The flow profile, dV/dt, for the healthy LV is shown in Fig. 2(a)
during diastole, and in Fig. 2(b) during systole (light gray curves), their
integral represents the stroke volume of 66.95 cm3. For comparison,
Fig. 2(a) also reports the time profile of QLV computed using Eq. (12),
which gives and integral VLV ¼ 67.25 cm3. Such agreement between
the volume change and the measured flow rate represents an indirect
agreement of the reliability of the present IBM calculation.
The systolic outflow in aorta in Fig. 2(b) is plotted together the
blood flow that crosses the LV annulus and returns to the atrium,
QMVa computed by (10) (continuous lines), and with the blood flow
that crosses the MV orifice, QMV computed by (8) (dashed lines), for
normal (healthy: black color) and prolapsed MVs (P3: blue, and P2:
red), respectively. The first part of systole corresponds to the closing
period of the MV, and here, the continuous and dashed curves differ
because QMVa includes the volume of blood contained in the MV pool
above the orifice that returns back to the atrium during MV closure;
afterward, the curves come together along a common path. The initial
difference represents the so-called false regurgitation that identifies the
physiological blood flow returning in the atrium during the closure of
FIG. 1. Flow field in the normal LV in the presence of a healthy MV [(a), and (d)] and MV with P3 Prolapse [(b), and (e)] and P2 Prolapse [(c), and (f)]. Diastolic flow at the
peak E-wave (a), (b), and (c), as indicated in the volume curve inset [black line in (g)]; the normal vorticity is shown in red to blue color from –200 units to 200 units equal to
the inverse of the heartbeat period and the velocity vector (every 4 grid points) on a longitudinal plane crossing the center of MV of aorta and the LV apex; the three-
dimensional gray surfaces represent one isosurface of the k2 parameter. The lower side is the three-dimensional flow field in the healthy LV calculated using the passive scalar
isosurface method at the same instants of early systole at a value of C¼ 0.4, as indicated in the volume curve inset. The inset in (g) reports the volume curve and the instant
of the case analyzed.
APL Bioengineering ARTICLE scitation.org/journal/apb
APL Bioeng. 3, 036105 (2019); doi: 10.1063/1.5097245 3, 036105-2
VC Author(s) 2019
the MV leaflets, which is estimated by the difference Vregfalse ¼
VregMVa  Vreg computed using (11) and (9). The same curves of regur-
gitating flow are shown in Fig. 2(c) limiting the calculation to the old
blood only, computed using Eq. (14). The overall entity or old blood
regurgitation is nearly proportional to the total regurgitations; never-
theless, it is evident that the old blood enters the atrium mainly during
the second half of systole when ejection has involved the entire LV vol-
ume. The initial regurgitation is mainly composed of fresh blood that
reached the region just behind the valve and is the first involved in the
back flow.
The integral results relative to all the different MVs are reported
in Table I. The healthy valve is a physiologic MV that presents a non-
zero EOA¼ 0.06 cm2, corresponding to a tiny hole with a 1% valve
size that is not caused by pathological valvular deformation or imput-
able to minor inaccuracy in image segmentation. The results show
how the increase in the EOA corresponds to an increase in Vreg , whose
correlation will be analyzed later. Regurgitation reaches about 10% of
the SV in the present P3 prolapse and about 20% in P2. It is noticed
that a small nonzero regurgitation is also found in healthy valves, indi-
cating that MV velocity during closure is slightly lower than blood
velocity. The false regurgitation, Vregfalse¼ VregMVa  Vreg , represents the
fresh atrial blood that does not cross the MV orifice and returns into
the atrium at the beginning of systole. This does not depend on the
EOA and is more a consequence of the MV shape.
Table II shows the volume of residual old blood stagnant into the
LV at end systole and the volume of old blood regurgitated in atrium.
These results show that the residual volume Vresidual is only moderately
influenced by the MV regurgitation that, therefore, does not directly
influence the LV wash-out. On the other hand, the increase in regurgi-
tation is associated with a larger percentage of old blood regurgitated
that reaches a value as high as 50% in the most diseased case.
The same analysis is repeated in correspondence with a patholog-
ical ventricular geometry corresponding to a severe dilated cardiomy-
opathy. The dilated LV is characterized by an enlarged end-diastolic
volume EDV ¼ 199:31ml, end-systolic volume (ESVÞ ¼ 142:50ml,
SV ¼ 56:82ml, and ejection-fraction EF ¼ 29%.
The flow field in the dilated LV at peak diastole is shown in Figs.
3(a)–3(c) in correspondence with (a) healthy, (b) P3, and (c) P2 MVs.
The overall intraventricular fluid dynamics in dilated ventricles was
FIG. 2. Flow balance in diastole. (a)
Comparison between diastolic dV/dt
(dashed dark line) and diastolic QLV (con-
tinuous gray line) in healthy LV. In systole,
(b) comparison of QMVa (continuous line)
and QMV (dashed line) for healthy-1MV
(dark line), P3 MVP (blue line), and P2
MVP (red line) and the gray continuous
line is the systolic dV/dt, (c) old blood flow
regurgitated in atrium, computed by QMVold
for healthy MV (dark line), P3 MVP (blue
line), and P2 MVP (red line); the gray con-
tinuous line is the systolic dV/dt.
TABLE I. Global results in healthy LV. MVA, mitral valve area; EOA, effective orifice area at the MV closed position; EOAMVA, EOA normalized with MVA; SV, Stroke volume;
VregMVa , total regurgitation; Vregfalse , false regurgitation; Vreg , regurgitation from orifice; and
Vreg
SV , Vreg normalized with SV.
MVA ðcm3Þ EOA ðcm3Þ EOAMVA ð%Þ SVðcm3Þ VregMVa ðcm3Þ Vregfalse ðcm3Þ Vreg ðcm3Þ
Vreg
SV ð%Þ
Healthy 6.20 0.06 1 66.95 2.07 1.64 0.43 0.65
P3 4.83 0.52 11 66.95 8.87 2.58 6.29 9.40
P2 4.26 0.87 20 66.95 13.42 0.66 12.76 19.07
P3-25% 4.83 0.39 8 66.95 4.57 2.49 2.08 3.11
P3-50% 4.83 0.26 5 66.95 2.58 1.00 1.58 2.37
P3-Healthy 4.83 0 0 66.95 1.70 0.90 0.80 1.20
TABLE II. Global transit results in healthy LV. EOAis the effective orifice area at the
MV closed position, Vresidual is the LV residual volume at end-systole, Vregold is the
quantity of the old blood regurgitated in atrium,
Vregold
Vreg
is the old blood regurgitated nor-
malized with Vreg , and Vresidual is the residual volume.
EOA ðcm2Þ Vresidual ð%Þ Vregold ðcm2Þ
Vregold
Vreg
ð%Þ
Healthy 0.06 28.50 0.03 6.98
P3 0.52 26.07 2.36 37.52
P2 0.87 30.67 6.42 50.31
P3-25% 0.39 25.28 0.70 33.65
P3-50% 0.26 25.60 0.09 5.70
P3-Healthy 0 26.12 0.01 1.25
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previously described in the literature,16,23 and it is qualitatively con-
firmed by the present results. All dynamic phenomena are weaker
because velocities are lower, and a slow circulation persists during a
large part of the heart cycle. In the dilated LV with healthy MV [Fig.
3(a)], the early diastolic jet enters into a chamber with quasiquiescent
fluid, and the ring propagates deeper in the large LV before it interacts
with the walls and partly dissipates. In the presence of pathological
MV [Figs. 3(b) and 3(c)], the mitral jet and the vortex ring at the jet’s
head present the same deviation previously noticed in the normal LV,
which is caused by the arrangement of the MVO. Figures 3(d)–3(f)
report the corresponding concentration field at peak systole. Blood is
well mixed between old and fresh blood but with the more marked
presence of old blood in the entire chamber caused by a larger size of
the pathological ventricle and reduced wash-out.
The flow profile, dV/dt, for the dilated LV is shown in Fig. 4(a)
during diastole and in Fig. 4(b) during systole (light gray curves); their
integral represents the stroke volume of 56.82 cm3. For comparison,
Fig. 4(a) reports the time profile of QLV computed using Eq. (12),
which gives and integral VLV ¼ 56.82 cm3. The systolic outflow in Fig.
4(b) is computed and reported using the same procedure described
above for the normal LV and confirms the presence of false regurgita-
tion at the beginning of systole. Similarly, the quantity of old blood
regurgitated, shown in Fig. 4(c), presents a trend that is similar to the
normal case.
Quantitative evaluations are obtained by the integral results
reported in Tables III and IV (to be compared with Tables I and II rel-
ative to normal LV). The values of regurgitation are comparable
between normal and dilated conditions in correspondence with the
FIG. 3. Flow field in the dilated LV in the presence of a healthy MV [(a) and (d)] and MV with P3 prolapse [(b) and (e)] and P2 prolapse [(c) and (f)]. Diastolic flow at the peak
E-wave (a)–(c), as indicated in the volume curve inset [black line in (g)]; the normal vorticity is shown by red to blue color from –200 units to 200 units equal to the inverse of
the heartbeat period and the velocity vector (every 4 grid points) on a longitudinal plane crossing the center of MV of aorta and the LV apex; the three-dimensional gray surfa-
ces represent one isosurface of the k2 parameter. The lower side is the three-dimensional flow field in the dilated LV calculated using the passive scalar isosurface method at
the same instants of early systole at a value of C¼ 0.4, as indicated in the volume curve inset. The inset (g) reports the volume curve and the instant of the case analyzed.
FIG. 4. Flow balance in diastole. (a): com-
parison between diastolic dV/dt (dashed
dark line) and diastolic QLV (continuous
gray line) in dilated LV. In systole, (b): com-
parison of the QMVa (continuous line) and
QMV (dashed line) for healthy-1MV (dark
line), P3-3 MVP (blue line), and P2 MVP
(red line); the gray continuous line is the
systolic dV/dt, (c): old blood flow regurgi-
tated in atrium, computed by QMVold for
healthy-1MV (dark line), P3-3 MVP (blue
line), and P2 MVP (red line); the gray con-
tinuous line is the systolic dV/dt.
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saved MV. This is true both in absolute and relative terms, considering
that the two LVs have a similar SV. A remarkable difference is found
in terms of wash-out, where the dilated LV presents a much larger
residual volume, independent of the MV. Also, the quantity of old
blood regurgitated is partially increased, indicating that some larger
amount of old blood returns back to the atrium and further reduces
the overall washout of the entire left heart, thus theoretically increasing
the risk of platelet activation and thrombus formation.
Figure 5(a) reports the correlation between the functional mea-
sure of valvular insufficiency, given by the regurgitant volume, and the
structural measure, given by the EOA. Once these values are properly
normalized, the two quantities present a direct proportionality,
Vreg
SV
ffi EOA
MVA
; (1)
with good accuracy without evident differences for the different types
of prolapse or the LV size. Figure 5(b) shows a good correlation
between the total regurgitation and the portion made of old blood;
however, some difference is noticeable between normal and dilated
LVs as previously underlined.
III. CONCLUSION
This numerical study provides some insights into the fluid
dynamics of mitral valve regurgitations. The calculation employed a
simplified model of MV deformation, based on clinical images, which
was found to be appropriate for flow modeling purposes. The analysis
has been performed for different prolapsed MVs inserted in both a
normal and a dilated LV.
First, the study evidenced the presence of a false regurgitation
made of blood that was in the MV cup and returned the atrium during
MV closure. In small prolapses, this false volume can be comparable
to the real regurgitation and should be considered in clinical
measurements.
The amount of regurgitation is principally due to the effective
insufficiency of the MV without a significant influence of the geometry
TABLE III. Global results in dilated LV. MVA, mitral valve area; EOA, effective orifice area at the MV closed position; EOAMVA, EOA normalized with MVA; SV, Stroke volume;
VregMVa , total regurgitation; Vregfalse ; false regurgitation; Vreg , regurgitation from orifice; and
Vreg
SV ; Vreg normalized with SV.
MVA ðcm2Þ EOA ðcm2Þ EOAMVA %ð Þ SV cm3ð Þ VregMVa ðcm3Þ Vregfalse ðcm3Þ Vreg ðcm3Þ
Vreg
SV ð%Þ
Healthy 6.20 0.06 1 56.82 2.41 2.40 0.10 0.18
P3 4.83 0.52 11 56.82 9.27 2.01 7.26 12.77
P2 4.26 0.87 20 56.82 11.74 0.04 11.70 20.60
P3-25% 4.83 0.39 8 56.82 5.78 1.96 3.82 6.73
P3-50% 4.83 0.26 5 56.82 3.53 2.05 1.48 2.61
P3-Healthy 4.83 0 0 56.82 3.02 2.01 1.01 1.77
TABLE IV. Global transit results in dilated LV. EOA is the effective orifice area at the
MV closed position, Vresidual is the LV residual volume at end-systole, Vregold is the
quantity of the old blood regurgitated in atrium,
Vregold
Vreg
is the old blood regurgitated nor-
malized with Vreg , and Vresidual is the residual volume.
EOA ðcm2Þ Vresidual ð%Þ Vregold ðcm2Þ
Vregold
Vreg
ð%Þ
Healthy 0.06 68.50 0.01 10
P3 0.52 69.79 3.74 51.51
P2 0.87 70.90 8.33 71.20
P3-25% 0.39 69.70 1.88 49.21
P3-50% 0.26 69.49 0.57 38.51
P3-Healthy 0 69.02 0.61 60.4
FIG. 5. Correlation between VregSV and
EOA
MVA
considering all MV cases and healthy LV
(square) and dilated LV (triangle) (a) and
Vreg and Vregold considering all MV cases
and healthy (square) and dilated LV (trian-
gle) (b).
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of the LV. The amount of regurgitating volume, expressed in percent-
age of the stroke volume, is found to be an equivalent measure of the
effective orifice area, expressed in percentage of the MV area. The
dimensions of the LV enter into play in terms of the quality of the
regurgitant blood; larger LVs present a reduced wash-out that reflects
in a larger percentage of old blood returning to the atrium, thus
increasing the risk of blood aggregation and thrombus.
IV. METHODS
A. Medical imaging and geometries
The healthy and dilated LV geometries used for numerical simu-
lation are obtained by 3D multislice CMR by combining three long-
axis borders corresponding to the 2-, 3-, and 4-chamber projections as
previously described.21 The entire LV endocardial surface is then
described by its 3D coordinates evaluated by interpolation on a struc-
tured mesh made of 768 points along the circumference and 384
points from the base to the apex; however, the results were indepen-
dent of the specific number of interpolation points.21 The LV geome-
try during all phases of the heartbeat is then described by the position
vector Xð#; s; tÞ of its endocardial surface, where the structured para-
metric coordinates, ð#; sÞ, run along the circumference and from the
base to the apex, respectively, and t is the time. The position vector
marks LV material points, and their velocity is obtained by time
differentiation.
The MV geometries were obtained in the fully open (at peak dias-
tole) and fully closed (during early systole) positions from clinical
imaging either computed tomography (CT) or 3D-transesophageal
echocardiography (TEE). Some MV geometries were obtained from
CT [Figs. 6(a) and 6(b)], these were first analyzed using segmentation
software (Mimics, Materialize, Leuven, Belgium) and exported to
Computer-Aided Drafting (CAD)-based software for digital process-
ing and mesh generation (3-matic, Materialize, Leuven, Belgium).
Differently, geometries from TEE [Fig. 6(c)] followed a different
processing procedure based on echocardiography-dedicated software
(4D MV-Assessment, TomTec Imaging Systems GmbH,
Unterschleissheim, Germany). In either cases, the extracted MV geom-
etries were eventually reorganized for convenience in terms of another
pair of parametric coordinates, ð#; sÞ, running along the circumference
and extending from the annulus to the trailing edge, respectively.
The analysis is performed on a series of MVs with different
degrees and types of prolapse. On the one end, a normal geometry
(called healthy-1) is used for reference, Fig. 6(a). MVP in Fig. 6(b) is a
prolapse P3 of type I MR with incomplete coaptation of the leaflet and
insufficient surface of coaptation of the leaflet and consequent reduc-
tion of the mitral valve area MVA. The MVP in Fig. 6(c) is a prolapse
P2 of type II MR with leaflet prolapsed caused by elongation of the
chordae tendineae. In addition, in order to evaluate intermediate con-
ditions, we have artificially modified the dimension of the P3 prolapse
by stretching the leaflets to let facing edges approach each other.
Figure 7 shows the MV geometry at end-systole with original prolapse
[P3, Fig. 7(a), equal to Fig. 7(b)], a reduction of 25% of the original
prolapse [P3–25%, Fig. 7(b)], of 50% [P3–50%, Fig. 8(c)] and the
100% correction to nonregurgitating geometry [P3-healthy, Fig. 8(d)].
Once the LV and MV geometries are obtained from images, the
MV and the aorta, assumed as a circular orifice, are placed at a proper
position relative to the LV. These valvular elements are then connected
to the LV annulus to close the valvular plane, as shown in Figs. 8(a)
and 8(b). Additionally, two straight regions are added extending the
aortic valve and the region around the MV (bounded by the LV annu-
lus and the line between MV and aorta) to the upper edge of the com-
putational domain; these represent surrogates of atrium and aorta
added for numerical convenience just to avoid mixing the inflow and
the outflow outside the LV, as shown in Figs. 8(c) and 8(d). An exam-
ple of a complete geometry with the different composing elements is
illustrated in Fig. 8. Ethical approval was not required for the anony-
mous geometric data used in this study.
FIG. 6. Closed and open configuration of
(a) healthy MV, (b) P3 prolapse, and (c)
P2 prolapse.
FIG. 7. Original MV with P3 prolapse (a),
modified MV with P3 prolapse reduced by
25% (b), reduced by 50% (c), and
reduced by 100% (d).
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Numerical simulations are performed with six different MVs in
both healthy and pathological LVs, which allows us to compile an ini-
tial general picture of fluid dynamics properties associated with the
evaluation of the regurgitation. Table V summarizes the different con-
ditions analyzed in the present study.
B. Valve dynamic model
MV imaging was best feasible in the fully open and fully closed
configuration because the time resolution of current imaging technol-
ogy is insufficient to reliably visualize the MV geometry during its
rapid motion. Therefore, the intermediate geometric configurations
FIG. 8. Composition of the complete
geometry of dilated LV with pathological
MV. (a) LV with the basal surface, (b) LV
with the basal surface and pathological
MV (with the leaflet semiopen), (c) LV with
the basal surface, pathological MV, and
atrium, (d) LV with the basal surface, path-
ological MV atrium, and aortic valve
(closed), (e) LV with the basal surface,
pathological MV atrium, aortic valve, and
arteria aorta, and (f) complete geometry.
APL Bioengineering ARTICLE scitation.org/journal/apb
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were reconstructed based on general geometrical arguments as follows.
The two leaflets were considered as moving independently, each one
associated with a degree of opening, say u1ðtÞ and u2ðtÞ, for the ante-
rior and posterior leaflets, respectively. The valve geometry at every
instant was thus described formally as Xv #; s; u1; u2ð Þ, which repre-
sents a two-dimensional set of intermediate positions associated with
the different degrees of leaflets’ openings. This set of possible geome-
tries is preliminarily estimated by interpolation between the closed
Xv #; s; 0; 0ð Þ, and open Xv #; s; p2 ; p2
 
configurations obtained from
images. Figure 9 shows an example of the different configurations that
the healthy MV can get in correspondence with different degrees of
opening of the two leaflets, u1 varying from 0 to
p
2 from left to right
and u2 increasing from top to bottom.
Once the parametric description Xv #; s; u1; u2ð Þ is available, a
dynamic equation for the opening angles is introduced as briefly
reported below; a comprehensive description and verification of the
computational method, including comparison with a fluid-structure-
interaction model with a given set of tissue parameters, are reported
elsewhere.4 The valvular leaflets are assumed to move with the flow
with no elastic resistance other than the constraint of remaining in the
set of configurations described by the two degrees of freedom. Under
this assumption, the leaflet dynamics is obtained by least-squares
minimization of the difference, integrated over the valvular surface Av ,
between the fluid and the valve velocity component normal to the val-
vular surface. This results in a 2 2 linear system,
ð ð
Av
@Xv
@u1
 n
 2
dA
ð ð
Av
@Xv
@u1
 n
 
@Xv
@u2
 n
 
dA
ð ð
Av
@Xv
@u1
 n
 
@Xv
@u2
 n
 
dA
ð ð
Av
@Xv
@u2
 n
 2
dA
2
66664
3
77775

@u1
@t
@u2
@t
2
664
3
775 ¼
ð ð
Av
v  nð Þ @Xv
@u1
 n
 
dA
ð ð
Av
v  nð Þ @Xv
@u2
 n
 
dA
2
6664
3
7775; (2)
for the two unknowns @u1@t and
@u2
@t , where v is the fluid velocity and n
is the local normal to the valvular surface.
The dynamic model described by system (2) represents an
asymptotic limit of the loosest MV within the prescribed set of geo-
metric configurations. As the model reproduces an asymptotic behav-
ior, it does not require the introduction of mechanical parameters of
the tissues that would be otherwise necessary for solving the momen-
tum equation for the solid. This is an advantage for applications where
such properties are not available; on the other hand, it should be
remarked that the model results are approximate and should be read
as a reference for the limiting behavior of real MVs.
This approach to valve dynamics represents a simplification with
respect to a complete modeling of valvular deformation based on the
actual elastic structure. Thus, this model neglects the forces due to elas-
tic recall (although they are commonly weak in normal MVs) and
reproduces the limiting behavior where the valve moves with the flow
with no elastic resistance other than the constraint of moving in the
prescribed set of geometrical configurations deducted from images, as
shown in Fig. 9 for the normal MV. This model represents an approxi-
mation with respect to a complete calculation with fluid-structure-
TABLE V. List of numerical simulations with different MVs and LVs.
MV LV LV
Healthy Healthy Dilated
P3 Healthy Dilated
P2 Healthy Dilated
P3-25% Healthy Dilated
P3-50% Healthy Dilated
P3-Healthy Healthy Dilated
FIG. 9. Geometry of a healthy MV for dif-
ferent degrees of opening of the two inde-
pendent leaflets. (a) u1 ¼ 0;u2 ¼ 0; (b)
u1 ¼ p6 ;u2 ¼ 0; (c) u1 ¼ p3 ;u2 ¼ 0;
(d) u1 ¼ p2 ;u2 ¼ 0; (e) u1 ¼ 0;u2
¼ p6; (f) u1 ¼ p6 ;u2 ¼ p6; (g) u1 ¼ p3 ;u2
¼p6; (h) u1¼p2 ;u2¼p6; (i) u1¼0;u2¼p3;
(j) u1¼p6 ;u2¼p3; (k) u1¼p3 ;u2¼p3; (l)
u1¼p2 ;u2¼p3; (m) u1¼0;u2¼p2; (n)
u1¼p6 ;u2¼p2; (o) u1¼p3 ;u2¼p2; and
(p)u1¼p2 ;u2¼p2.
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interaction, and it is not aimed to analyze the details of MV deforma-
tion. On the other hand, it has the advantage of not requiring a
detailed definition of tissue properties that cannot be measured
in vivo. This simplifies the solution that is aimed to reproduce the
main properties of the LV fluid dynamics in the presence of a moving
MV, assumed to have loose moving elements, when the general prop-
erties of the valvular structure are not available. A systematic analysis
of the properties and limitations of such a valvular modeling for flow
simulation is reported in a dedicated methodological study.4 This
approach also neglects the influence of chordae tendineae whose effect
is replaced by constraining the valve from opening toward the atrium.
The aortic valve, downstream the LV outlet tract, is modeled as a
simple orifice with open/close behavior; the aortic valve (AV) opens
when the MV is closed, and the average normal velocity at the valve
position is directed toward the aorta.
C. Numerical model
The governing equations for the flow are the Navier-Stokes equa-
tion and continuity equation
@v
@t
þ v  rv ¼ rpþ r2v; (3)
r  v ¼ 0; (4)
where vðt; xÞ is the fluid velocity vector field, pðt; xÞ is the kinematic
pressure field, and  is the kinematic viscosity (assumed 0.04 cm2/s) of
blood assumed as a Newtonian fluid.
The numerical solution is based on the immersed boundary
method (IBM) extensively described in previous studies.2,4–7,15,16
Briefly, Eq. (3) is discretized in a rectangular domain using a staggered,
face-centered regular Cartesian grid where spatial derivates are
approximated by second-order centered finite differences. The bound-
ary conditions at the edge of the computational box are set periodic in
the x and y directions, while they are zero pressure and normal veloc-
ity on the upper and lower ends along z, respectively. The surfaces
described in Sec. IV are used as immersed boundaries; to this end, the
computational cells that are cut by those surfaces are assumed as
impermeable and no-slip elements with a prescribed velocity vector
equal to that of the corresponding immersed boundary. The time
advancement of fluid velocity and valve dynamics, given by Eqs. (3)
and (2), respectively, is obtained using a third-order Runge-Kutta
explicit scheme. The continuity constrain (4) is then satisfied by a frac-
tional step method by solution of a Poisson equation.5
D. Flow transit analysis
The analysis of flow transit allows evaluating the properties of the
washout and/or stagnation inside the LV chamber and identifying the
origin of the regurgitant blood.
This analysis is performed here by solving a transport-diffusion
equation for a passive scalar. Let Cðx; tÞ be the concentration of a pas-
sive marker of particles; the diffusion-transport equation is
@C
@t
þ v  rC ¼ r2C; (5)
which can be solved in parallel to the Navier-Stokes equation starting
from the initial condition C x; 0ð Þ ¼ 1; in this way, the individual
blood particles present in the LV at end-systole are marked. The time
evolution of C allows us to verify the washout of the LV and if the
blood ejected or regurgitated is made of blood that was previously pre-
sent in the LV (marked by C ¼ 1) or that just arrived from the atrium
(C ¼ 0).
In order to create a link with the existing literature in 4D Flow
MRI, we compute the LV wash-out in terms of the residual volume,9
which is defined by the blood volume that was present in the LV before
diastole and that is not expelled during systole. The residual volume,
normalized with the end-systolic volume (ESV), can be evaluated as
Vresidual ¼ 1ESV
ð
ESV
CdV: (6)
The increase in the residual volume corresponds to an increased
possibility of blood aggregation.
E. Regurgitation analysis
We describe here the methods used for the numerical calculation
of MR properties. The effective area of the MV orifice area is com-
puted by measuring the space between the leaflets’ trailing edge
MVO tð Þ ¼
ðL
0
Xeant  Xepost
 dL; (7)
where Xe ¼ Xvð#; 1Þ is the trailing edge that is subdivided into the
anterior and posterior leaflets and L is the length of a curve running
along the midpoint between the two edges. The EOA of a regurgitant
orifice is the MVO evaluated from (7) during systole when the MV is
in the closed configuration.
The calculation of the blood flow rate effectively crossing the MV
orifice is computed by
QMV tð Þ ¼
ðL
0
vrel  n Xeant  Xepost
 dL; (8)
where the relative velocity, vrel ¼ v  @@t
XeantXepost
2 ; is the difference
between the fluid velocity averaged along the line between the two fac-
ing edges and the velocity of the edges themselves and n is the local
normal. From this, the regurgitating blood volume is the flow crossing
the MVO during systole
Vreg ¼
ð
sys
QMV tð Þdt: (9)
It will also be useful, for comparison, to compute the blood volume
crossing the MV annulus (MVa) to separate the contribution due to
leaflet motion
QMVa tð Þ ¼
ð
AMVa
vrelMVa  nð ÞdA (10)
where AMVa is the area of MVa and the relative velocity vrelMVa
¼ vMVa  @XMVa@t is the difference between the fluid velocity averaged
over the MVa and the average velocity of the annulus, with XMVa
being the average position vector of the MV annulus. Then, the regur-
gitating blood volume measured across the MVa is
VregMVa ¼
ð
sys
QMVa tð Þdt: (11)
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For further reference, we have also considered the flow crossing the
LV annulus
QLV tð Þ ¼
ð
ALVa
vrelLVa  nð ÞdA; (12)
where ALVa is the area of LVa and the relative velocity vrelLVa
¼ vLVa  @X LVa@t is the difference between the fluid velocity averaged
over the LVa and the average velocity of the annulus, with XLVa being
the average position vector of the LV annulus. Then, the blood volume
measured across the LVa is
VLVa ¼
ð
dia
QLV tð Þdt: (13)
The same evaluations introduced above can be extended to define the
quality of blood present in these volumes. The knowledge of the con-
centration field, computed by (5), allows recognizing the amount of
flow that is composed of blood that was present in the LV before the
beginning of diastole (hereafter indicated as old) or, by difference, that
entered the LV during last diastole (fresh).
The old blood volume regurgitated by the MV orifice is obtained
by extending (8) as
QMVold tð Þ ¼
ðL
0
vrel  n Xeant  Xepost
 C dLAMVa ; (14)
where C is the concentration measured at the MV orifice; the corre-
sponding volume is
Vregold ¼
ð
sys
QMVold tð Þ dt: (15)
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